Stay updated on Filgotinib and Lanraplenib in Female CLE Clinical Trial

Sign up to get notified when there's something new on the Filgotinib and Lanraplenib in Female CLE Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Filgotinib and Lanraplenib in Female CLE Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Lakefront Biotherapeutics NV was added as a collaborator and Galapagos NV was removed from the study's Collaborators and Investigators list.
    Difference
    0.0%
    Check dated 2026-05-25T10:22:38.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, indicating a small platform update.
    Difference
    0.0%
    Check dated 2026-05-18T04:15:30.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The page’s site revision/version indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-26T15:31:27.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T13:50:18.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    - Revision: v3.5.0 has been added, replacing Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T20:09:40.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T06:11:22.000Z thumbnail image

Stay in the know with updates to Filgotinib and Lanraplenib in Female CLE Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Filgotinib and Lanraplenib in Female CLE Clinical Trial page.